Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 375

Sort by

Sort Order Select

Journal Articles

Outcome after 3 rd Line Treatment for Diffuse Large B-Cell Lymphoma: A Danish Population-Based Study

Blood (2022) 140 (Supplement 1): 6706–6707.

https://doi.org/10.1182/blood-2022-167897

Published: 2022

Journal Articles

Analysis of Factors Predicting Treatment Response of 254 Patients Who Received CD19-Targeted CAR-T Cell Therapy for Relapsed/Refractory (R/R) B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Xian Zhang, MD, Junfang Yang, MD, Yanze Shi, Dan Song, Jingjing Li, Xin-an Lu, PhD, Fei Wu, Jianqiang Li, Ph. D., Dandan Chen, Xiangqun Li, Zhongwei Xu, Shuqiang Liu, Ziyu Li, Kui YIng, Wenya Wang, Peihua Lu

Blood (2019) 134 (Supplement_1): 224.

https://doi.org/10.1182/blood-2019-125503

Published: 2019

Journal Articles

Peak Lymphocyte Count after CAR T Infusion Is a Clinically Accessible Test That Correlates with Clinical Response in Axicabtagene Ciloleucel Therapy for Lymphoma

Blood (2019) 134 (Supplement_1): 4106.

https://doi.org/10.1182/blood-2019-127094

Published: 2019

Journal Articles

Effect of Cyclosporine Inhalation Solution (CIS) on Lung Function and Inflammatory Biomarkers in Patients with Hematopoietic Stem Cell Transplant (HSCT) Associated Bronchiolitis Obliterans Syndrome (BOS)

Janhavi Athale, MD, Nicole J Gormley, MD, Robert Reger, MS, Sara Alsaaty, MS, Debra Reda, BSN, Tatyana Worthy, MSN, Ankit Saxena, Ph. D, Xin Tian, Ph. D, Richard W. Childs, MD, Anthony F Suffredini, MD

Blood (2019) 134 (Supplement_1): 4552.

https://doi.org/10.1182/blood-2019-122966

Published: 2019

Journal Articles

Prognostic Validation of Diffuse Large B Cell Lymphoma International Prognostic Index for High Grade B Cell Lymphoma with and without MYC and BCL2 or BCL6 Rearrangements: An Institutional Review

Gowthami Kanagalingam, MD, Vrinda Vyas, MBBS, Alina Basnet, MBBS, Garry Brooks, Dr. PH, Alexandria Smith, MD

Blood (2019) 134 (Supplement_1): 5362.

https://doi.org/10.1182/blood-2019-132066

Published: 2019

Journal Articles

Retrospective Analysis of the Efficacy of Triplet Therapy, Including Lenalidomide, in Newly Diagnosed Multiple Myeloma Patients Who Obtained Responses Less Than VGPR after Rd Therapy

Naoki Takezako, MD PhD, Naoya Kaneko, MD, Airi Hamano, Ph, Kenichi Ito, MD, Naohiro Sekiguchi, MD, Satoshi Noto, MD, Takanori Teshima, MD

Blood (2019) 134 (Supplement_1): 5595.

https://doi.org/10.1182/blood-2019-131617

Published: 2019

Journal Articles

Novel Genetic Variations in Acute Myeloid Leukemia in a South Asian Population

Saba Shahid, PhD, Dr. Mohammad Shakeel, Ph. D, Saima Siddiqui, FCPS, Shariq Ahmed, MPhil, Misha Sohail, MSc, Ishtiaq Ahmed, Tahir S. Shamsi, MBBS,FRCPath

Blood (2019) 134 (Supplement_1): 5185.

https://doi.org/10.1182/blood-2019-129674

Published: 2019

Journal Articles

Maintenance with Weekly Carfilzomib in Elderly Newly Diagnosed Multiple Myeloma (IFM 2012-03)

Arthur Bobin, Guillemette Fouquet, Alain Duhamel, PU/PH, Salomon Manier, MD PhD, Lionel Karlin, MD, Brigitte Kolb, MD, Mourad Tiab, MD, Carla Araujo, MD, Nathalie Meuleman, PhD MD, Jean Valère Malfuson, MD, Pascal Bourquard, MD, Pascal Lenain, MD, Arnaud Jaccard, MD PhD, Karim Belhadj, MD, Michel Attal, MD PhD, Philippe Moreau, MD, Cyrille Hulin, MD, Xavier Leleu, MD PhD

Blood (2019) 134 (Supplement_1): 3190.

https://doi.org/10.1182/blood-2019-131793

Published: 2019

Journal Articles

A Nationwide Survey on Chronic Active Epstein-Barr Virus Infection in Japan Based on New Diagnostic Criteria: Clinical Features and Treatment Strategies

Ayako Arai, MD PhD, Ichiro Yonese, Chizuko Sakashita, MD PhD, Ken-Ichi Imadome, PhD, Tohru Kobayashi, MD PhD, Akihisa Sawada, MD PhD, Yoshinori Ito, MD PhD, Shouichi Ohga, MD PhD, Hiroshi Kimura, MD, Ph. D., Shigeyoshi Fujiwara, MD, PhD

Blood (2018) 132 (Supplement 1): 1631.

https://doi.org/10.1182/blood-2018-99-117854

Published: 2018

Journal Articles

Activation of Hottip lncrna Perturbs HSC Function Leading to AML like Disease in Mice

Huacheng Luo, Ganqian Zhu, PhD, Jie Zha, MD, Bowen Yan, Ph. D, Ying Guo, Jianfeng Xu, PhD, Qian Lai, Bing Xu, MD PhD, Feng-Chun Yang, MD PhD, Wei Li, Yi Qiu, Mingjiang Xu, MD PhD, Suming Huang

Blood (2018) 132 (Supplement 1): 3877.

https://doi.org/10.1182/blood-2018-99-110218

Published: 2018

Journal Articles

Clinical Outcome Associated with Cytomegalovirus (CMV) Infection/Disease in CMV-Seropositive Adult Patients after Allogeneic Hematopoietic Stem Cell Transplantation

Regis Peffault De Latour, Patrice Chevallier, MD, Didier Blaise, Aurore Clement, Thierry Allavoine, Abir Tadmouri, PhD, Josefin Blomkvist, Alain Duhamel, PU/PH, Ibrahim Yakoub-Agha, MD PhD

Blood (2018) 132 (Supplement 1): 3382.

https://doi.org/10.1182/blood-2018-99-112151

Published: 2018

Journal Articles

The Clinical Utility of Pharmacogenomics Testing in Assessing Tyrosine Kinase Inhibitor Therapy, Intolerance and Responses in Patients with Chronic Myelogenous Leukemia

Blood (2018) 132 (Supplement 1): 5440.

https://doi.org/10.1182/blood-2018-99-118600

Published: 2018

Journal Articles

Targeted Next Generation Sequencing for Myeloid Neoplasm in Pakistani Patients

Saba Shahid, Ph. D, Shariq Ahmed, MPhil, Saima Siddiqui, FCPS, Misha Sohail, MSc, Tahir S. Shamsi, MBBS, FRCPath

Blood (2018) 132 (Supplement 1): 5137.

https://doi.org/10.1182/blood-2018-99-113766

Published: 2018

Journal Articles

The Presence of Defective Epstein-Barr Virus (EBV) Infection in Patients with EBV-Associated Hematological Malignancy

Yusuke Okuno, MDPhD, Takayuki Murata, MD, PhD, Yoshitaka Sato, MD, PhD, Hideki Muramatsu, MD PhD, Yoshinori Ito, MD PhD, Takahiro Watanabe, D.MD, PhD, Tatsuya Okuno, MD, Norihiro Murakami, MD, Kenichi Yoshida, MD PhD, Akihisa Sawada, MD PhD, Masami Inoue, MD, Keisei Kawa, MD, PhD, Masao Seto, MD PhD, Koichi Ohshima, MDPhD, Yuichi Shiraishi, PhD, Kenichi Chiba, PhD, Hiroko Tanaka, BA, Satoru Miyano, PhD, Yohei Narita, PhD, Masahiro Yoshida, MD PhD, Fumi Goshima, PhD, Junichi Kawada, MD PhD, Tetsuya Nishida, MD PhD, Hitoshi Kiyoi, MD PhD, Seiichi Kato, MD, PhD, Shigeo Nakamura, MD PhD, Satoko Morishima, MD PhD, Shigeyoshi Fujiwara, MD, PhD, Norio Shimizu, PhD, Yasushi Isobe, MD, PhD, Masaaki Noguchi, MD, PhD, Atsushi Kikuta, MD, Keiji Iwatsuki, MD, PhD, Yoshiyuki Takahashi, MD, PhD, Seiji Kojima, MD PhD, Seishi Ogawa, MD PhD, Hiroshi Kimura, MD, Ph. D.

Blood (2018) 132 (Supplement 1): 1562.

https://doi.org/10.1182/blood-2018-99-113801

Published: 2018

Journal Articles

Multi-Disciplinary Obstetrics and Sickle Cell Disease Clinic in Low Resource Setting Lowers Maternal and Perinatal Death Rates to the Same Levels As Those without Sickle Cell Disease

Samuel A Oppong, MD, Edeghonghon Olayemi, MBBS, MSc, Yvonne Adomakoh, MBBS, Eugenia Vicky Asare, MBChB, BSc, Enoch Mensah, HND, Alim Swarray-Deen, MD, Yvonne Osei-Bonsu, Dip(PH), Selina Crabbe, Dip(PH), Latif Musah, BSc, Theodore Boafor, MBChB, Brittany Covert, MPH, CCRP, Adetola A. Kassim, MD MS, Andra H. James, MDMPH, Mark Rodeghier, PhD, Michael R. DeBaun, MD MPH

Blood (2017) 130 (Supplement 1): 616.

https://doi.org/10.1182/blood.V130.Suppl_1.616.616

Published: 2017

Journal Articles

Brentuximab Vedotin Plus Doxorubicin, Vinblastine, Dacarbazine (A+AVD) As Frontline Therapy Demonstrates Superior Modified Progression-Free Survival Versus ABVD in Patients with Previously Untreated Stage III or IV Hodgkin Lymphoma (HL): The Phase 3 Echelon-1 Study

Blood (2017) 130 (Supplement 1): 6.

https://doi.org/10.1182/blood.V130.Suppl_1.6.6

Published: 2017

Journal Articles

Disruption of CTCF Boundary Remodels Chromatin Domain and Reprograms HOX Gene Transcription in Acute Myeloid Leukemia

Huacheng Luo, PhD, Fei Wang, MDPhD, Haoli Li, PhD, Qinghua Du, MD, Bowen Yan, Ph. D, Shi Chen, Baoan Chen, MDPhD, Yi Qiu, PhD, Mingjiang Xu, MDPhD, Suming Huang, PhD

Blood (2017) 130 (Supplement 1): 244.

https://doi.org/10.1182/blood.V130.Suppl_1.244.244

Published: 2017

Journal Articles

Adjusting Dosage of Mercaptopurine By NUDT15 Polymorphisms in Childhood Acute Lymphoblastic Leukemia

Der-Shiun Wang, MD, Chih-Hsiang Yu, Ph. D student, Wen-Chien Chou, MD, PhD, Ya-Hsuan Chang, Chien-Yu Lin, Kai-Hsin Lin, Shiann-Tarng Jou, MD PhD, Meng Yao Lu, MD, Hsiu-Hao Chang, MD PhD, Shu-Wha Lin, PhD, Dong-Tsamn Lin, Professor, Hsuan-Yu Chen, Ph. D, Yung-Li Yang, MD PhD

Blood (2017) 130 (Supplement 1): 2566.

https://doi.org/10.1182/blood.V130.Suppl_1.2566.2566

Published: 2017

Journal Articles

Safety and Activity of the Highly Specific BTK Inhibitor BGB-3111 in Patients with Indolent and Aggressive Non Hodgkin's Lymphoma

Constantine S. Tam, MBBS, MD FRACP, FRCPA, David Simpson, MBChB, Stephen Opat, FRACP, FRCPA, Won Seog Kim, MD, Ph. D., Michael Wang, MD, Gavin Cull, MB, BS, FRACP, FRCPA, Patrick B Johnston, MD PhD, Javier Munoz, MD, Won-Sik Lee, MD, Paula Marlton, MBBS, David Gottlieb, MBBS, MD FRACP, FRCPA, Lai Wang, PhD, Jane Huang, MD, James Hilger, Ling Xue, PhD, Sunhee Ro, PhD, Judith Trotman, FRACP

Blood (2017) 130 (Supplement 1): 152.

https://doi.org/10.1182/blood.V130.Suppl_1.152.152

Published: 2017

Journal Articles

Low Body Mass Index in Pregnant Women with Sickle Cell Disease Is Associated with Premature Delivery in Sub- Saharan Africa

Eugenia Vicky Asare, MBChB, BSc, Edeghonghon Olayemi, MBBS, MSc, Yvonne Adomakoh, MBBS, Enoch Mensah, HND, Alim Swarray-Deen, MD, Harriet Ghansah, BSc, Yvonne Osei-Bonsu, Dip(PH), Selina Crabbe, Dip(PH), Latif Musah, BSc, Charles Hayfron-Benjamin, MBChB, Theodore Boafor, MBChB, Brittany Covert, MPH, CCRP, Adetola A. Kassim, MD MS, Andra H. James, MDMPH, Mark Rodeghier, PhD, Michael R. DeBaun, MD MPH, Samuel A Oppong, MD

Blood (2017) 130 (Supplement 1): 2250.

https://doi.org/10.1182/blood.V130.Suppl_1.2250.2250

Published: 2017

NARROW

Outcome after 3 rd Line Treatment for Diffuse Large B-Cell Lymphoma: A Danish Population-Based Study

Analysis of Factors Predicting Treatment Response of 254 Patients Who Received CD19-Targeted CAR-T Cell Therapy for Relapsed/Refractory (R/R) B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Peak Lymphocyte Count after CAR T Infusion Is a Clinically Accessible Test That Correlates with Clinical Response in Axicabtagene Ciloleucel Therapy for Lymphoma

Effect of Cyclosporine Inhalation Solution (CIS) on Lung Function and Inflammatory Biomarkers in Patients with Hematopoietic Stem Cell Transplant (HSCT) Associated Bronchiolitis Obliterans Syndrome (BOS)

Prognostic Validation of Diffuse Large B Cell Lymphoma International Prognostic Index for High Grade B Cell Lymphoma with and without MYC and BCL2 or BCL6 Rearrangements: An Institutional Review

Retrospective Analysis of the Efficacy of Triplet Therapy, Including Lenalidomide, in Newly Diagnosed Multiple Myeloma Patients Who Obtained Responses Less Than VGPR after Rd Therapy

Novel Genetic Variations in Acute Myeloid Leukemia in a South Asian Population

Maintenance with Weekly Carfilzomib in Elderly Newly Diagnosed Multiple Myeloma (IFM 2012-03)

A Nationwide Survey on Chronic Active Epstein-Barr Virus Infection in Japan Based on New Diagnostic Criteria: Clinical Features and Treatment Strategies

Activation of Hottip lncrna Perturbs HSC Function Leading to AML like Disease in Mice

Clinical Outcome Associated with Cytomegalovirus (CMV) Infection/Disease in CMV-Seropositive Adult Patients after Allogeneic Hematopoietic Stem Cell Transplantation

The Clinical Utility of Pharmacogenomics Testing in Assessing Tyrosine Kinase Inhibitor Therapy, Intolerance and Responses in Patients with Chronic Myelogenous Leukemia

Targeted Next Generation Sequencing for Myeloid Neoplasm in Pakistani Patients

The Presence of Defective Epstein-Barr Virus (EBV) Infection in Patients with EBV-Associated Hematological Malignancy

Multi-Disciplinary Obstetrics and Sickle Cell Disease Clinic in Low Resource Setting Lowers Maternal and Perinatal Death Rates to the Same Levels As Those without Sickle Cell Disease

Brentuximab Vedotin Plus Doxorubicin, Vinblastine, Dacarbazine (A+AVD) As Frontline Therapy Demonstrates Superior Modified Progression-Free Survival Versus ABVD in Patients with Previously Untreated Stage III or IV Hodgkin Lymphoma (HL): The Phase 3 Echelon-1 Study

Disruption of CTCF Boundary Remodels Chromatin Domain and Reprograms HOX Gene Transcription in Acute Myeloid Leukemia

Adjusting Dosage of Mercaptopurine By NUDT15 Polymorphisms in Childhood Acute Lymphoblastic Leukemia

Safety and Activity of the Highly Specific BTK Inhibitor BGB-3111 in Patients with Indolent and Aggressive Non Hodgkin's Lymphoma

Low Body Mass Index in Pregnant Women with Sickle Cell Disease Is Associated with Premature Delivery in Sub- Saharan Africa

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only